d,l-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells
- 1 July 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 8 (7), 1946-1954
- https://doi.org/10.1158/1535-7163.mct-09-0104
Abstract
D,l-Sulforaphane (SFN), a synthetic analogue of cruciferous vegetable–derived l-isomer, inhibits the growth of human prostate cancer cells in culture and in vivo and retards cancer development in a transgenic mouse model of prostate cancer. We now show that SFN treatment causes transcriptional repression of androgen receptor (AR) in LNCaP and C4-2 human prostate cancer cells at pharmacologic concentrations. Exposure of LNCaP and C4-2 cells to SFN resulted in a concentration-dependent and time-dependent decrease in protein levels of total AR as well as Ser210/213-phosphorylated AR. The SFN-mediated decline in AR protein level was accompanied by a decrease in intracellular as well as secreted levels of prostate-specific antigen, an AR-regulated gene product. The decrease in AR protein level resulting from SFN exposure was not reversed in the presence of the protein synthesis inhibitor cycloheximide. Reverse transcription-PCR analysis revealed a dose-dependent decrease in AR mRNA levels, indicating transcriptional repression of this ligand-activated transcription factor. The SFN treatment inhibited AR promoter activity as revealed by luciferase reporter assay. Synthetic androgen (R1881)–stimulated nuclear translocation of AR was markedly suppressed in the presence of SFN in both cell lines. The SFN treatment also inhibited R1881-stimulated proliferation of LNCaP cells. Naturally occurring thio analogues (iberverin, erucin, and berteroin), but not the sulfonyl analogues (cheirolin, erysolin, and alyssin sulfone), of SFN were also effective in reducing protein levels of AR in LNCaP cells. In conclusion, the present study shows for the first time that SFN treatment causes transcriptional repression of AR and inhibition of its nuclear localization in human prostate cancer cells. [Mol Cancer Ther 2009;8(7):1946–54]Keywords
This publication has 48 references indexed in Scilit:
- Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart SizeScience Signaling, 2011
- Cellular Responses to Cancer Chemopreventive Agent D,L-Sulforaphane in Human Prostate Cancer Cells Are Initiated by Mitochondrial Reactive Oxygen SpeciesPharmaceutical Research, 2009
- Sulforaphane Inhibits Prostate Carcinogenesis and Pulmonary Metastasis in TRAMP Mice in Association with Increased Cytotoxicity of Natural Killer CellsCancer Research, 2009
- Calpain‐mediated androgen receptor breakdown in apoptotic prostate cancer cellsJournal of Cellular Physiology, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1Carcinogenesis: Integrative Cancer Research, 2007
- Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cellsOncogene, 2005
- Bax and Bak Are Required for Apoptosis Induction by Sulforaphane, a Cruciferous Vegetable–Derived Cancer Chemopreventive AgentCancer Research, 2005
- NF-κB and TNF-α stimulate androgen receptor expression in Sertoli cellsMolecular and Cellular Endocrinology, 2003
- Androgen Receptor: An OverviewCritical Reviews™ in Eukaryotic Gene Expression, 1995